Top of the morning, everyone. Today marks the start of the earnings season for drug makers - Johnson & Johnson is reporting - and voting starts on healthcare reform. So lots to keep an eye on. Hope your day goes well....
Pfizer Slow To Address Chantix Side Effects in Korea (Korea Times)
Pfizer Criticized Over Worker Safety (The Korea Times)
Johnson & Johnson Third-Quarter Earnings (Press Release)
Vanda License Schizo Drug To Novartis (MarketWatch)